678 results found | searching for "pharma"

First Previous 1 2 3 4 5 6 7 8 9 10 Next Last 
  • Lizahayden
  • HighStreetPharma is one of the best online pharmacies. There are various FDA-approved medications available with express shipment worldwide. HighStreetPharma is a one-stop shop for all of your requirements that has been in business for a decade, delivering inexpensive items to your home with free quick shipping worldwide. See what our clients have to say about our service by reading the 600+ reviews on our website. https://techmorereview.com/companies/highstreetpharma/ [more]
  • yamunapharmacy
  • Best Ayurvedic Medicine Manufacturer in Haryana | Yamuna Pharmacy Are you seeking the best herbal medicine manufacturer in Haryana? Connect with Yamuna Pharmacy! We manufacture effective medicines and provide ayurveda franchises across the nation. If you want to expand your business, Visit https://yamunapharmacy.com/ now! [more]
  • Healthcare_medical
  • 3D Cell Culture Market Development Analysis, Share and Recent Trends By 2027 https://bit.ly/3PorEFl The report "3D Cell Culture Market Size, Growth by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region - Global Forecast to 2027", is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6%. The Scaffold-based 3D cell cultures subsegment accounted for the largest share of the type segment in the 3D cell culture market. Based on type, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures accounted for the largest share. The advantages of scaffolds in 3D cell culture, such as structural rigidity, the availability of attachment points, and support, have greatly driven the preference for scaffold-based 3D cell cultures and ensured the large share of this segment. [more]
  • vatori
  • Farooq Hospital DHA Farooq Group of Companies is a group which is well reputed well known and progressive having multi directional businesses. Under the health sector of the company different projects are being run with a highly professional and ethical spirit. Talking about Farooq Hospitals it’s important to know that in 1985 a 35 bedded hospital was established by Dr. Farooq Saeed Khan at main boulevard Allama Iqbal town Lahore and it was his dedication, honesty, professionalism, and commitment which attracted the community and people trusted him for their health problems. In 1993 the board of directors made a decision to work aggressively to meet the mission and for this purpose, they decided to establish Medical schools, Nursing schools, Dental colleges, and pharmacy colleges. In addition to this decisions were taken to establish a chain of hospitals including the extension of Farooq Hospital Allama Iqbal Town, Lahore. In accordance with the mission and strategic plans following projects have been completed. In 1995, an extension of Farooq Hospital was done. The most important decision was to address the poor community for which a 100% Charity based hospital was planned. In 2000, Akhtar Saeed Trust Hospital started its working and now it’s a 300 bedded 100% Charity based teaching hospital. In 2008, Akhtar Saeed Medical College was started with the aim to produce good doctors. In 2012 rightly according to the mission and strategic plan a state of the art and equipped with most modern high end facilities, Farooq Hospital west wood was established. It is a 220 bedded hospital out of which 120 beds are dedicated for the poor patients and community services. Considering the dire need of good medical facility in DHA, Farooq Group of Companies embarked on the journey of starting another exemplary hospital in the heart of DHA. Located on main ghazi road, Farooq Hospital DHA is the largest private hospital in Lahore. It is the most modern and high-end hospital with 300+ beds. A place where a legacy of highly trusted professionals, latest diagnostic, surgical facilities and reliable medical specialties are available. The hospital already has 80 plus consultants in the OPD, all of which are the top notch doctors in the city. The OPD is actively seeing patient and patients can book their appointments. Farooq hospital Lahore contact number are 042-35732242- 042-35709673- 042-35709938. Farooq hospital doctors list can be seen on the website or details of specific doctors can be reached through the numbers provided. Farooq hospital lahore address is P Block, DHA, Main, Ghazi Rd, near Rehman Gardens, Lahore, Punjab. For directions Farooq hospital lahore map follow this link: https://goo.gl/maps/cMkympPYjuiBePQH6
  • Healthcare_medical
  • 3D Cell Culture Market Expected To Raise At CAGR of 15.6% By 2022-2027 | Top Companies https://bit.ly/3PorEFl The report "3D Cell Culture Market Size, Growth by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region - Global Forecast to 2027", is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6%. [more]
  • Healthcare_medical
  • Global Infrared & Terahertz Spectroscopy Market Insights and In-Depth Analysis 2022-2025 https://bit.ly/3FSTWEU The report "Infrared & Terahertz Spectroscopy Market by Instrument Type (Benchtop Instruments, Microscopy Instruments, Portable Instruments, Hyphenated Instruments), Spectrum, Application - Global Forecast to 2025" The infrared spectroscopy market is expected to reach USD 1.3 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.2% during the forecast period. The key factors driving the growth of this market are the stringent regulations in the pharmaceutical industry, increasing food safety concerns & technological advancements. [more]
  • jameshebrew
  • The combination product services market is anticipated to grow at a CAGR of around 10%, till 2035, claims Roots Analysis Growing interest for combination products, coupled with the ongoing challenges of combining drug / biologic with a medical device, is anticipated to drive the demand for outsourcing combination products development and testing. Roots Analysis has announced the addition of “Combination Product Services Market, 2022-2035” report to its list of offerings. The development of drug-device combination products is a long-drawn-out process that not only requires novel technologies and processes but also a huge amount of capital and expertise. In order to overcome these challenges and enhance overall patient experience, several developers are outsourcing their operations to companies that offer services for testing and validation of combination products. Key Market Insights Currently, more than 25 service providers claim to offer services for combination products The market is dominated by the presence of small (11-50 employees) and mid-sized (51-500 employees) players, who represent over 55% of the contemporary market landscape. Additionally, it is worth noting that majority (81%) of the service providers are based in North America. Around 70% of the players engaged in this industry offer services for drug delivery device / system Over 65% of the aforementioned players offer services for product development. Further, 60% of the combination product service providers offer services for prefilled syringes. Notably, over 70% of the total players engaged in this space also offer process development and validation services. Go / No-Go framework can be used to assist players in the outsourcing decision-making process The framework enables evaluation of the current capabilities of prefilled syringe combination product developers and aids them to take the crucial decision of outsourcing / in-house development and testing of prefilled syringe combination products based on 5+ parameters. Expansion activity within this field has grown significantly between 2017 and 2022 Maximum number of expansion initiatives (38%) were undertaken in 2021. It is worth highlighting that majority of the expansions were facility expansions. Notably, over 70% of the expansion initiatives have been undertaken for facilities based in North America. North America and Europe are anticipated to capture larger share (over 65%) of market by 2035 Growth in this domain is anticipated to be primarily driven by the rising demand of combination products. Players providing performance testing services are anticipated to capture more than 75% of the market by 2035. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/combination-product-services-market/request-sample.html The financial opportunity within the Combination Product Services (Focus on Particle Testing, Performance Testing and Product Development) Market has been analyzed across the following segments:  Type of Device  Service Focus Area  Company Size  Geographical Regions For additional details, please visit https://www.rootsanalysis.com/reports/combination-product-services-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Medical Devices Contract Research Organization Market (3rd Edition), 2022-2035 2. Prefilled Syringes Market (6th Edition), 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com [more]
  • arif12
  • Lactic Acid Market Research Report Size, Growth & Global Forecast – 2022-2029 The Lactic Acid Market is expected to expand at a significant CAGR of 11.5% during the forecast period (2022-2029). The factors driving the growth of Lactic Acid Market includes increasing application of lactic acid across end-use industries such as pharmaceuticals and food and beverages, rising focus on reducing carbon emissions, growing use of lactic acids in skincare products and cosmetic therapies and improvements in the living standards. More Info, Click to Access Complete Report – http://jobhop.co.uk/blog/17095/lactic-acid-market-research-report-size-growth--global-forecast--2022-2029 [more]
  • jameshebrew
  • The rare kidney disorders market is projected to grow at a CAGR of 17%, during the period 2022-2035, claims Roots Analysis Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases London Roots Analysis has announced the addition of the “Rare Kidney Disorders Market, 2022–2035” report to its list of offerings. More than 90 candidates targeting rare kidney disorders are currently under clinical investigation, while several novel leads are being evaluated in the early stages of development. Given the lucrative opportunity associated with these targets, this domain has gained attention of both private and public investors in the past few years. As more candidates are likely to progress towards the advanced stages of development, we expect the market to witness aggressive growth in the foreseen future. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/rare-kidney-diseases-market/request-sample.html Key Market Insights More than 125 drug candidates targeting rare kidney disorders are currently under development Over 25 total pipeline candidates are available in the market across various geographical regions. Of these, 43% have been approved for the treatment of cystinosis, Fabry disease and lupus nephritis. Further, majority of the approved / under development drugs (47%) are designed for delivery via oral route. Over 60 companies are engaged in the development of drugs targeting rare kidney disorders Since 2006, 27 companies have been established in this domain. Further, around 60% of the developers are large and very large firms. In addition, majority (68%) of the players engaged in the development of drugs against rare kidney disorder are based in North America, primarily in the US. Partnership activity in domain has increased at an annualized rate of >92%, during 2017-2021 It is worth mentioning that the maximum number of partnerships were inked in 2018 and 2019. Further, product development and commercialization agreements emerged as the most popular type of partnership model adopted by rare kidney disorder targeting drug developers, representing over 25% of the total instances. USD 3.5+ billion has been invested by both private and public investors, since 2017 The maximum funding amount was raised through venture fundings (26%), debt financing (23%) and private equity (18%), during the period 2017-2021. Interestingly, around 85% of the funding instances were reported by players based in North America. North America is anticipated to capture over 30% of the global market share in 2035 In the long term, close to 40% of the market revenues are expected to be generated from sales of therapeutics targeting lupus nephritis. Further, therapies designed for delivery via the oral route are expected to occupy a larger share (41%) of the overall market in 2035. The financial opportunity within the rare kidney disorder market has been analysed across the following segments:  Type of Molecule  Route of Administration  Target Indications  Key Geographical Regions For additional details, please visit https://www.rootsanalysis.com/reports/rare-kidney-diseases-market.html You may also be interested in the following titles: 1. Cell Therapy Manufacturing Market: Industry Trends and Global Forecasts, 2022-2035 2. CAR-T Cell Therapy Market (4th Edition): Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com [more]
  • tradevision
  • What is pharmaceutical import export data? How to import and export pharma products? Which countries buy and sell the most pharmaceuticals? Download pharmaceuticals export import data here. https://bit.ly/3uDqOe4
First Previous 1 2 3 4 5 6 7 8 9 10 Next Last